Jones R N, Barrett M S, Biedenbach D J
Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City 52242.
Diagn Microbiol Infect Dis. 1994 Jun;19(2):93-9. doi: 10.1016/0732-8893(94)90119-8.
Preliminary susceptibility testing interpretive criteria were determined for two investigational drugs, DU-6859a and FK-037, when tested against Haemophilus influenzae and Neisseria gonorrhoeae strains. National Committee for Clinical Laboratory Standards (NCCLS) methods with the Haemophilus Test Medium and GC agar base were utilized, and the study design conformed to the NCCLS M23-A guidelines. The proposed H. influenzae susceptibility testing criteria were for DU-6859a susceptible at < or = 1 microgram/ml (5-micrograms disk zone diameter correlate, > or = 19 mm) or < or = 2 micrograms/ml (disk zone diameter correlate, > or = 16 mm) and for FK-037 susceptible at < or = 2 micrograms/ml (30-micrograms disk zone diameter correlate, > or = 19 mm). No other susceptibility categories were proposed. The gonococcal susceptibility testing criteria were for DU-6859a susceptible at < or = 0.12 microgram/ml (disk zone diameter correlate, > or = 34 mm) and for FK-037 susceptible at < or = 0.5 microgram/ml (disk zone diameter correlate, > or = 30 mm) and resistant at > 1 microgram/ml (disk zone diameter correlate, < or = 26 mm). No resistant criterion was proposed for N. gonorrhoeae tests with DU-6859a. No interpretive discrepancies were observed between methods using these proposed testing criteria.
对两种研究性药物DU - 6859a和FK - 037进行针对流感嗜血杆菌和淋病奈瑟菌菌株的初步药敏试验时,确定了解释标准。采用国家临床实验室标准委员会(NCCLS)的方法,使用嗜血杆菌测试培养基和GC琼脂基础培养基,研究设计符合NCCLS M23 - A指南。提议的流感嗜血杆菌药敏试验标准为:DU - 6859a在≤1微克/毫升(5微克纸片抑菌圈直径对应值,≥19毫米)或≤2微克/毫升(纸片抑菌圈直径对应值,≥16毫米)时为敏感;FK - 037在≤2微克/毫升(30微克纸片抑菌圈直径对应值,≥19毫米)时为敏感。未提议其他药敏类别。淋病奈瑟菌药敏试验标准为:DU - 6859a在≤0.12微克/毫升(纸片抑菌圈直径对应值,≥34毫米)时为敏感;FK - 037在≤0.5微克/毫升(纸片抑菌圈直径对应值,≥30毫米)时为敏感,在>1微克/毫升(纸片抑菌圈直径对应值,≤26毫米)时为耐药。针对使用DU - 6859a进行的淋病奈瑟菌试验,未提议耐药标准。使用这些提议的试验标准的方法之间未观察到解释差异。